Continuous intraperitoneal insulin infusion versus subcutaneous insulin for type 1 diabetes: a prospective, case-control trial proving non-inferiority

被引：0
|
作者：
Bilo, H. J. G. [1 ]
van Dijk, P. R. [1 ]
Logtenberg, S. J. J. [1 ]
Groenier, K. H. [1 ]
Feenstra, H. [2 ]
Gans, R. O. B. [3 ]
Kleefstra, N. [1 ]
机构：
[1] Isala Clincs, Ctr Diabet, Zwolle, Netherlands
[2] Diaconessenhuis, Meppel, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
193
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [41] Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
    Ruff, Christian T.
    Baron, Michelle
    Im, KyungAh
    O'Donoghue, Michelle L.
    Fiedorek, Fred T.
    Sabatine, Marc S.
    NATURE MEDICINE, 2022, 28 (01) : 89 - +
  • [42] Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
    Christian T. Ruff
    Michelle Baron
    KyungAh Im
    Michelle L. O’Donoghue
    Fred T. Fiedorek
    Marc S. Sabatine
    Nature Medicine, 2022, 28 : 89 - 95
  • [43] Glycemic Control in Adult Type 1 Diabetes Patients with Insulin Glargine, Insulin Detemir, or Continuous Subcutaneous Insulin Infusion in Daily Practice
    Rautiainen, Paivi
    Tirkkonen, Hilkka
    Laatikainen, Tiina
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (05) : 363 - 369
  • [44] A prospective study using Continuous Subcutaneous Insulin Infusion (CSII) for Type 1 diabetes in a single centre
    Solomon, A. M.
    Nethaji, C.
    Holland, J.
    Vanderpump, M.
    Press, M.
    DIABETIC MEDICINE, 2008, 25
  • [45] Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control
    Radermecker, R. P.
    Renard, E.
    Scheen, A. J.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (06) : 491 - 501
  • [46] Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial
    van Bon, Arianne C.
    Bode, Bruce W.
    Sert-Langeron, Caroline
    DeVries, J. Hans
    Charpentier, Guillaume
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (06) : 607 - 614
  • [47] Continuous subcutaneous insulin infusion therapy for Type 1 diabetes mellitus in children
    M. Mavinkurve
    A. Quinn
    C. S. O’Gorman
    Irish Journal of Medical Science (1971 -), 2016, 185 : 335 - 340
  • [48] Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Pregnant Women with Type 1 Diabetes
    Gonzalez-Romero, Stella
    Gonzalez-Molero, Inmaculada
    Fernandez-Abellan, Micaela
    Dominguez-Lopez, Marta E.
    Ruiz-de-Adana, Soledad
    Olveira, Gabriel
    Soriguer, Federico
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (04) : 263 - 269
  • [49] Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus
    Hasselmann, C.
    Bonnemaison, E.
    Faure, N.
    Mercat, I.
    Pepin-Donat, M. Bouillo
    Magontier, N.
    Chantepie, A.
    Labarthe, F.
    ARCHIVES DE PEDIATRIE, 2012, 19 (06): : 593 - 598
  • [50] Continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes
    Siegel, L
    Schachner, H
    Vargas, I
    Goland, R
    DIABETES, 2001, 50 : A67 - A67
12345